Comparison of europium and chromium release assays: Cytotoxicity in healthy individuals and patients with cervical carcinoma

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 2, 1997, Pages 202-207

  Von Zons, Peter ^a   Crowley Nowick, Peggy ^b   Friberg, Diana ^c,d   Bell, Maria ^e   Koldovsky, Ursula ^a   Whiteside, Theresa L ^c,d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; EUROPIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

EID: 0030895497     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.2.202-207.1997     Document Type: Article

References (21)

1. Blomberg, K., C. Granberg, I. Hemmila, and T. Lovgren. 1986. Europiumlabeled target cells in an assay of natural killer cell activity. I. A novel non-radioactivity method based on time resolved fluorescence. J. Immunol. Methods 86:225-229.
2. Blomberg, K., C. Granberg, I. Hemmila, and T. Lovgren. 1986. Europium-labeled target cells in an assay of natural killer cell activity. II. Significance and specificity of the method. J. Immunol. Methods 92:117-123.
3. Blomberg, K., and A. Ulfstedt. 1993. Fluorescent europium chelates as target cell markers in the assessment of natural killer cell cytotoxicity. J. Immunol. Methods 160:27-34.
4. Blomberg, K. 1994. Simultaneous measurement of natural killer cell cytotoxicity against each of three different target cell lines. J. Immunol. Methods 168:267-273.
5. Bohlen, H., O. Manzke, A. Engert, M. Hertel, R. Hippler-Altenburg, V. Diehl, and H. Tesch. 1994. Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporation. J. Immunol. Methods 173:55-62.
6. 51Cr-Iabelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181-196.
7. Bryant, J, R. Day, T. L. Whiteside, and R. B. Herberman. 1992. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J. Immunol. Methods 146:91-103.
8. Granberg, C., K. Blomberg, I. Hemmila, and T. Lovgren. 1988. Determination of cytotoxic T lymphocyte activity by time-resolved fluorometry using europium-labelled concanavalin A-stimulated cells as targets. J. Immunol. Methods 114:191-195.
9. Hemmila, I., S. Dakubu, V.-M. Mukkala, H. Siitari, and T. Lovgren. 1984. Europium as a label in time resolved immunoflourometric assays. Anal. Biochem. 137:335-343.
10. Heo, D. S., J.-G. Park, K. Hata, R. Day, R. B. Herberman, and T. L. Whiteside. 1990. Evaluation of tetrazolium-based semi-automatic colorimetric assay for measurement of antitumor cytotoxicity. Cancer Res. 50:3681-3690.
11. Larson, M. S. 1994. Invasive cervical cancer rising in young white females. J. Natl. Cancer Inst. 86:6-7.
12. Lovgren, J., and K. Blomberg. 1994. Simultaneous measurement of NK cell cytotoxicity against two target cell lines labelled with fluorescent lanthanide chelates. J. Immunol. Methods 173:119-125.
13. Maley, D., and P. Simon. 1990. Cytotoxicity assay using cryopreserved target cells pre-labeled with the fluorescent marker europium. J. Immunol. Methods 134:61-70.
14. Parkin, M. D. 1988. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer 41:184-197.
15. Pross, H. F., M. G. Baines, P. Rubin, P. Shagge, and M. S. Patterson. 1981. Spontaneous human lymphocyte mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J. Clin. Immunol. 1:51-63.
16. Schiffman, M. H., M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Sherman, R. J. Kurman, and S. Wacholder et al. 1993. Epidemiologic evidence showing that human papilloma virus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:958-964.
17. Soini, E., and H. Kojola. 1983. Time-resolved fluorometer for lanthanide chelates - a new generation of non-isotopic immunoassays. Clin. Chem. 29: 65-68.
18. Vaquer, S., J. Jorda, E. Lopez de la Osa, J. Alvarez de los Heros, N. Lopez-Gracia, and M. Alvarez de Mon. 1989. Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix. Gynecol. Oncol. 36:90-92.
19. Volgmann, T., A. Klein-Struckmeier, and H. Mohr. 1989. A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity. J. Immunol. Methods 119:45-51.
20. Whiteside, T. L., J. Bryant, R. Day, and R. B. Herberman. 1990. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J. Clin. Lab. Anal. 4:102-114.
21. Whiteside, T. L., and R. B. Herberman. 1994. Role of human natural killer cells in health and disease. Clin. Diagn. Lab. Immunol. 1:125-133.